The Labor Law Insider: Beware the Unfair Labor Practice - Not Just for Unions Anymore
JONES DAY TALKS®: Women in IP: 2020 in Review and a Look Toward 2021
KT Sound Bytes Episode 1 | The Effects of the Supreme Court Decision in Liu v. SEC
JONES DAY PRESENTS®: Trade Secret Enforcement in the United Kingdom
JONES DAY TALKS®: Straight Talk About False Advertising: What Every Lawyer Needs to Know
Bar Exam Toolbox Podcast Episode 86: Tackling a California Bar Exam Essay: Remedies
Episode 5: Business Divorce, Delaware Style
Should Wall Street Fear Mary Jo White?
For years, the U.S. International Trade Commission maintained that the potent remedies available under Section 337 were unavailable to intellectual property owners considered to be nothing more than “mere importers.” That...more
In borrowing a page from the '80s band "Men Without Hats," on June 12, 2017, the U.S. Supreme Court brought greater certainty for both biosimilar applicants and originator companies. In Sandoz Inc. v. Amgen Inc., the Supreme...more
On January 13, 2017, the Supreme Court granted certiorari in Amgen v. Sandoz, 794. F.3d 1347 (Fed. Cir. 2015) and Sandoz v. Amgen, 773 F.3d 1274 (Fed. Cir. 2014), appealed from the Federal Circuit. The petitions involve the...more
The U.S. Supreme Court has agreed to review some of the patent dispute resolution provisions of the Biologics Price Competition and Innovation Act (BPCIA). The Court granted certiorari in the dispute between Amgen and Sandoz,...more
On Friday, Jan. 13, the Supreme Court granted the appellant’s petition and the respondent’s cross-petition for a writ of certiorari in Sandoz Inc. v. Amgen Inc. This is the first time the Court will construe the Biologics...more
Supreme Court Abolished Federal Circuit's Test for Willfulness - On June 13, 2016, in Halo Electronics, Inc. v. Pulse Electronics, Inc., 579 U.S. ___ (2016), the Supreme Court unanimously abrogated the Federal Circuit’s...more